Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.

Circulation research - 19 Feb 2016

Nordestgaard Børge G

Abstract excerpt

Scientific interest in triglyceride-rich lipoproteins has fluctuated over the past many years, ranging from beliefs that these lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) to being innocent bystanders. Correspondingly, clinical recommendations have fluctuated from a need to reduce levels to no advice on treatment. New insight in epidemiology now suggests that these lipoproteins, marked by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Cholesterol, HDL
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertriglyceridemia

Share to Hypolipidemic Agents

Share to Lipoproteins

Share to Primary Prevention

Share to Triglycerides

Source

Identifiers

PMID: 26892957
DOI: 10.1161/CIRCRESAHA.115.306249

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.PMID 26892957Read ↗

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic StudiesSemantic proximity Read ↗

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.Semantic proximity Read ↗

Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.Semantic proximity Read ↗

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.Semantic proximity Read ↗

Exploring the Causal Roles of Circulating Remnant Lipid Profile on Cardiovascular and Cerebrovascular Diseases: Mendelian Randomization StudySemantic proximity Read ↗

Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.Semantic proximity Read ↗

Beyond Cholesterol: A Comprehensive Review and Disease Architecture Reassessment of Lipid and Lipoprotein Biomarkers in ASCVDSemantic proximity Read ↗

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.Semantic proximity Read ↗

Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization StudySemantic proximity Read ↗

Genetics of Triglycerides and the Risk of AtherosclerosisSemantic proximity Read ↗

Cardiometabolic Risks: Cellular and Molecular MechanismsSemantic proximity Read ↗

Causal Associations Between Remnant Cholesterol Levels and Atherosclerosis-Related Cardiometabolic Risk Factors: A Bidirectional Mendelian Randomization AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.